Skip to main content
. 2026 Sep 1;18(9):1099. doi: 10.3390/pharmaceutics18091099
CNS Central nervous system
FGF-1 Fibroblast growth factor-1
GI Gastrointestinal
GSH Reduced glutathione
GSSG Oxidized glutathione
LCIG Levodopa–carbidopa intestinal gel
MDS-UPDRS Movement disorder society-unified Parkinson’s disease rating scale
MRS Magnetic resonance spectroscopy
MSC Mesenchymal stem cell
OFF Medication “off” state
ON Medication “on” state
PD Parkinson’s disease
PK Pharmacokinetics
PLGA Poly(lactic-co-glycolic acid)
ROS Reactive oxygen species
UPDRS Unified Parkinson’s disease rating scale